Animal Models Shared Resource Animal models are powerful cancer research tools and a vital link in translating laboratory studies Into the clinic. The function of the Animal Models Shared Resource (AMSR) is to facilitate efficient economical, and state-of-art use of animals for the performance of cancer-related studies. This is accomplished through a centralized resource, where AALAS-certified, highly trained veterinary technicians provide preclinical research services to LCCC members. A significant emphasis is placed on assisting users with the design and performance of animal studies using a wide-range of models, including zebrafish and a recently developed model to study endocrine resistance and breast cancer recurrence in an estrogen receptor positive rat model. Major services provided include all aspects of rodent studies, such as establishing genetically modified mouse colonies, administrating carcinogens, monitoring tumor growth, collecting tissues and tumors at necropsy, and administering drugs, diets or other compounds. Studies using zebrafish include generating gene knockout or gene overexpressing models, screening for toxicity/drugs, and xenotransplantation experiments. Imaging services are also provided to monitor tumor initiation, progression, and response to therapy. The imaging services provided by AMSR include high resolution in vivo small animal imaging and image analysis using a recently upgraded Bruker 7-Tesla magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) console, a small animal ultrasound (Vevo660) workstation, an X-ray imaging unit (Faxitron) and a visible-near infrared spectroscopic imaging workstation (Maestro II). The AMSR is located within Georgetown University Medical School's Division of Comparative Medicine (DCM). The DCM is a centralized, AAALAC-accredited, USDA-registered animal facility and has an approved letter of assurance on file at the NIH. In 2012, these services were used in support of peer reviewed projects of 18 LCCC members from all four Research Programs. The AMSR is codirected by Leena Hilakavi-Clarke, PhD, and Christopher Albanese, PhD, who oversee the animal and imaging components, respectively

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA051008-21
Application #
8698918
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-08-15
Project End
2019-04-30
Budget Start
2014-09-09
Budget End
2015-04-30
Support Year
21
Fiscal Year
2014
Total Cost
$187,144
Indirect Cost
$66,794
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Tassi, Elena; Garman, Khalid A; Schmidt, Marcel O et al. (2018) Fibroblast Growth Factor Binding Protein 3 (FGFBP3) impacts carbohydrate and lipid metabolism. Sci Rep 8:15973
Lipkus, Isaac M; Mays, Darren (2018) Comparing harm beliefs and risk perceptions among young adult waterpipe tobacco smokers and nonsmokers: Implications for cessation and prevention. Addict Behav Rep 7:103-110
Speidell, Andrew P; Demby, Tamar; Lee, Yichien et al. (2018) Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy. Neurotox Res :
Rebbeck, Timothy R (see original citation for additional authors) (2018) Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat 39:593-620
Coia, Heidi; Ma, Ning; Hou, Yanqi et al. (2018) Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High-Fat Diet-induced Hepatocarcinogenesis by Theaphenon E. Cancer Prev Res (Phila) 11:665-676
Lee, Yichien; Rodriguez, Olga C; Albanese, Chris et al. (2018) Divergent brain changes in two audiogenic rat strains: A voxel-based morphometry and diffusion tensor imaging comparison of the genetically epilepsy prone rat (GEPR-3) and the Wistar Audiogenic Rat (WAR). Neurobiol Dis 111:80-90
Ozawa, Patricia Midori Murobushi; Alkhilaiwi, Faris; Cavalli, Iglenir João et al. (2018) Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells. Breast Cancer Res Treat 172:713-723
Ory, Virginie; Kietzman, William B; Boeckelman, Jacob et al. (2018) The PPAR? agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ. Breast Cancer Res Treat 169:47-57
Edwardson, Matthew A; Zhong, Xiaogang; Fiandaca, Massimo S et al. (2018) Plasma microRNA markers of upper limb recovery following human stroke. Sci Rep 8:12558
Smith, Jill P; Wang, Shangzi; Nadella, Sandeep et al. (2018) Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. Cancer Immunol Immunother 67:195-207

Showing the most recent 10 out of 1120 publications